The condition affects adults primarily older than 65. Though Parkinson’s disease itself is separated into five stages, Parkinson’s disease dementia isn’t as well understood. People with ...
THE GLOBAL prevalence of Parkinson’s disease is projected to more than double by 2050, reaching 25.2 million cases, with ...
Researchers at the WEHI Parkinson’s Disease Research Centre have made a huge leap forward in the fight against Parkinson’s disease, solving a decades-long mystery. In a major breakthrough, they have ...
Researchers say structure reveals many new ways to change PINK1, essentially switching it on, which will be "life-changing" for people with Parkinson’s disease.
Teleneurorehabilitation provides similar improvement in motor and nonmotor symptoms for patients with Parkinson’s disease as ...
With MeiraGTx eyeing up how to take the drug through phase 3 and onto commercialization, Hologen has stepped in. The AI-focused company is handing over $200 million as an upfront payment, as well as ...
MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson's and CNS treatments.